Pharmalot… Pharmalittle… Morning Coffee
Make a commentBy Ed Silverman // December 20th, 2007 // 7:46 am
Rise and shine. We can tell the pace is slowing down for many people, but we remain busy. And so here are a few items to keep you occupied as you sort through the morning…
EC Approves Hospira’s Version Of J&J’s Procrit (PharmaTimes)
Lilly’s Taurel Takes A Cut Without CEO Pay (Bloomberg News)
Canadian Rx Growth Slows, But Generics Soar (PharmaTimes)
Par Pharma’s Quarterly Revenue Rises (MarketWatch)
FDA Issues Non-Approvable Letter To Indevus For Bladder Drug (Forbes/AP)